Purpose. To establish situations in which family physicians (FPs) consider pulse oximetry a valuable addition to their clinical patient assessment; to explore pulse oximetry results (SpO 2 ) when used by FPs in patients with chronic obstructive pulmonary disease (COPD); to explore associations between SpO 2 and other markers of COPD severity.
Introduction
Pulse oximetry is a non-invasive method allowing monitoring of the oxygenation of a patient's haemoglobin in a matter of seconds. In the past years, lowcost pulse oximetry has been an important technological advancement. Due to small size, user-friendliness and affordable prices, hand-held pulse oximeters have become available for use in primary care. Despite the wide range of potential applications pulse oximetry may offer to primary care doctors, very little research has been reported about its use in primary care. The limited data that have been reported show that pulse oximetry can be used in patients with acute respiratory insufficiency (including acute asthma attacks) and in the follow-up of patients with chronic respiratory conditions. 1 Pulse oximetry may also be helpful in diagnosing diabetic peripheral arterial disease, 2 in screening for congenital heart disease in children 3 and in predicting mortality risk in patients with a pulmonary embolus. 4 Measuring oxygen saturation by pulse oximetry may also be a useful test to demonstrate systemic hypoxia in patients with acute exacerbations of chronic obstructive pulmonary disease (COPD). 5 Our current Dutch family practice guideline for COPD recommends that in case of an exacerbation of COPD, respiratory failure is unlikely to be present with an arterial oxyhaemoglobin saturation measured with pulse oximetry (SpO 2 ) >92%. 6 The choice to initiate oxygen therapy in acute COPD exacerbations based on an oxygen saturation value <90% is considered another possible application for pulse oximetry in primary care. 7 In a study by Giesen et al. 8 based on a retrospective medical record analysis of patients contacting a family physicians (FPs) cooperative, the value of pulse oximetry was especially recognized for patients previously unknown to the FP who presented with acute medical problems. The occasions in which FPs in the UK most often use pulse oximetry is in patients who present with an exacerbation of COPD. 9 Based on FPs' self-reports in this particular study, pulse oximetry may affect FPs medical decision making in 20% of COPD exacerbations.
The available literature suggests that the use of pulse oximetry by FPs would be limited to acute events or specific groups of patients only, but currently, there is no clear picture about the full range of indications for which FPs may use pulse oximetry. FPs who have experience in using the device in their daily routine are likely to have a rather good view of the various situations in which pulse oximetry supports their clinical decision making. Therefore, the first aim of the research reported in this paper was to establish in which particular situations FPs who are experienced in using pulse oximetry consider this measurement a valuable addition to their regular clinical patient assessment. More specifically, we wanted to generate a shortlist of explicit indications for the use of pulse oximetry by FPs. Further building upon these results, our study's second aim was to explore pulse oximetry results when this measurement is used by FPs in their routine care for patients with COPD who present with worsening of symptoms. Our third and final aim was to explore associations between SpO 2 and other markers of disease severity in stable as well as exacerbated COPD.
Materials and Methods
We used a combination of qualitative and quantitative research methods. Three subsequent studies were performed. Study I was an interview study followed by a Delphi consensus procedure 10 with 11 FPs experienced in using pulse oximetry. This explorative study was conducted first in order to generate an overview and priority ranking of indications for pulse oximetry in family practice. Study II was an analysis of case reports of patients with COPD who had consulted an FP because of their respiratory condition and in which the FP had performed pulse oximetry. For Study III, we used spirometry and pulse oximetry data from patients with stable COPD who had visited a primary care diagnostic centre. The Medical Ethics Review Board of the Radboud University Nijmegen Medical Centre approved the studies.
Study I: interview and Delphi study in FPs
Eleven FPs who owned a pulse oximeter were recruited through the customer list of a national reseller of medical equipment (PT Medical BV, Leek, The Netherlands) and were interviewed by telephone. A short questionnaire was developed to structure the interviews. The participating FPs received this questionnaire before the scheduled interview appointment. The FPs were first asked to describe the last two patients in whom they had used their pulse oximeter. After that the interview focused on their general experiences and opinions about the situations in which they felt pulse oximetry had additional value in daily patient care. Additional information enquired consisted of: years of experience as a FP, years of experience in using pulse oximetry, reasons for having purchased a pulse oximeter and frequency of use of the pulse oximeter. All interviews were recorded on audiotape. Transcripts of the interviews were independently assessed by two of the investigators (TS and JL) in order to extract indications for pulse oximetry as mentioned by the FPs throughout the interviews. The two investigators compared their observations, which resulted in an initial listing of indications for pulse oximetry in family practice. Next, the indications were subdivided in two categories, 'acute situations' and 'non-acute situations'. This categorized list of all indications was send back to the interviewed FPs with the instruction to (i) first add any indications for pulse oximetry they felt were still missing; (ii) delete indications they considered to be irrelevant and (iii) rank the remaining indications according to their perceived relevance within the two categories (acute and non-acute situations) using rank numbers. Indications that a FP considered to be least important were ranked lowest by that particular FP.
Study II: pulse oximetry in COPD patients consulting a FP Nine FPs were recruited to participate in a field study regarding the application of pulse oximetry. The FPs were equipped with a pulse oximeter (9550 Onyx II, Nonin Medical Inc., Plymouth, MN) and were instructed to use the equipment in all patients with COPD who consulted them with worsening of their respiratory symptoms. The FPs recorded the indication for applying pulse oximetry [either 'acute exacerbation', defined as an acute deterioration of COPD symptoms and/or signs that led the FP to treat the patient according to Dutch family practice guideline recommendations for the management of acute COPD exacerbations, 6 'increased dyspnoea' (without other symptoms and/or signs of an acute COPD exacerbation) or 'other'] and SpO 2 , as well as additional information about the patient (age, gender, exacerbation, respiratory symptoms and relevant co-morbidity) and whether or not the pulse oximetry had influenced decision making. Results of recent (i.e. <6 months ago) spirometry tests performed when the patient was in stable condition were extracted from the patients' medical files to establish COPD severity. 
Analysis
Based on the ranked indication lists of the FPs in Study I, median rank numbers and interquartile ranges were calculated within the categories of acute and non-acute situations. In Studies II and III, patients with COPD were categorized according to the Global Initiative for Obstructive Lung Disease (GOLD) severity stages (stage I-III). An SpO 2 value <92% was considered a positive test result. 5, 6, 12 Proportions of positive tests and their 95% confidence intervals (CIs) were calculated. Because of the skewed distribution of the SpO 2 values, median and Kruskal-Wallis tests were used to analyse differences between subgroups of patients, and Spearman rank correlation coefficients were calculated to analyse associations between SpO 2 and FEV 1 % predicted in Studies II and III.
Results
Indications for pulse oximetry from interviews with FPs (Study I) For Study I, 9 of 11 interviewed FPs (82%) returned their list with ranked indications for pulse oximetry. Mean age of these FPs was 45.0 (SD 9.3, range 33-62) years and all but one was male. Their mean professional experience as a FP was 14.4 (range 2-32) years, their mean experience of working with a pulse oximeter 1.8 (range 1-4) years. The average frequency of pulse oximetry use was 14.5 (range 0.5-70) times per week. Table 1 shows the indications for pulse oximetry as mentioned and subsequently ranked by the FPs. For acute situations (14 indications overall), the highest ranked indication was objectification in patients who present with acute dyspnoea or with worsening of preexisting dyspnoea. Other important indications in acute situations were to assess the severity of a lower respiratory tract infection and to assess the severity of an exacerbation in patients with COPD. In non-acute situations (11 indications overall), the highest ranked indication was to objectify a suspicion of respiratory failure in patients with COPD, followed by establishing a baseline value in patients with chronic airways disease in general (Table 1) .
Apart from the listing and ranking of indications, the interviews with the FPs also elucidated the value they attached to using pulse oximetry in their daily work. The FPs considered pulse oximetry especially of value when on out of office hours shift in their family practice cooperative, as a supportive tool to decide whether or not to send a patient to an emergency department or to refer to a medical specialist. The FPs also considered pulse oximetry of additional value to direct their decisions on which medication to prescribe in case of an exacerbation of COPD. All interviewed FPs stated that a pulse oximeter should be included in the standard equipment package of a FP. An important note made by the FPs during the interviews was the fact that pulse oximetry should be considered an adjunct in the diagnostic assessment of patients, not as a full diagnostic tool by itself.
Pulse oximetry in COPD patients with acute exacerbations or increased dyspnoea (Study II)
The results of our interviews and subsequent Delphi study as well as previous studies 1, 9 showed that FPs consider patients with COPD as an important group for pulse oximetry use. Therefore, we further explored this specific group of patients with regard to the value of pulse oximetry when applied in family practice. A total of 88 patients with COPD were included. According to the FPs, nine of these patients had an indication for pulse oximetry other than an acute exacerbation or increased dyspnoea (e.g. follow-up after an earlier exacerbation, hospital admission or diagnostic prednisolone test, central cyanosis, determination of appropriate exercise level). In three patients, the FP failed to record the indication for pulse oximetry. Table 2 shows that the proportion of patients with SpO 2 <92% was 19.4% (95% CI 6.8, 32.0) in patients in which the FP considered an acute exacerbation the indication for pulse oximetry, compared to 24.5% (95% CI 11.3, 37.7) in patients with increased dyspnoea as the indication. According to the FPs, the outcome of the SpO 2 measurement had influenced their decision making in 44.8% (95% CI 33.8, 55.8) of cases. Spearman correlation coefficient for the association between baseline FEV 1 % predicted as documented in the patient's medical file and SpO 2 was r = 0.55 (P = 0.002) for patients with acute exacerbations and r = 0.31 (P = 0.144) for patients with increased dyspnoea as the indication for pulse oximetry (Fig. 1) .
Pulse oximetry in patients with stable COPD (Study III) Data from the primary care diagnostic centre were available for 207 patients with COPD ranging from GOLD stages I to III (table 3) . Thirteen patients (6.3% of the study population) showed clinically relevant SpO 2 values (<92%): 5 GOLD I patients, 7
GOLD II patients and 1 GOLD III patient. The latter patient also showed the lowest SpO 2 value observed (87%). A weak correlation existed between post-bronchodilator FEV 1 % predicted and SpO 2 values (Spearman r = 0.19, P = 0.006, see Figure 2 ; for current smokers: r = 0.13, P = 0.252 and for former smokers: r = 0.19, P = 0.047). Median SpO 2 values did not differ between GOLD stages (median test: P = 0.079). A statistically significant association between MRC scores and SpO 2 values was observed (median test: P = 0.019). Current smoking status was not associated with SpO 2 (P = 0.166, Kruskal-Wallis test). Family Practice-an international journal
Discussion

Main findings
The first aim of our study was to establish in which particular situations FPs who are experienced in using pulse oximetry consider this measurement a valuable addition to their regular clinical patient assessment. We were able to generate a list of explicit indications and priorities for FPs' use of pulse oximetry in acute and non-acute situations. They valued it highest in patients with acute (worsening of) dyspnoea, suspected respiratory insufficiency or failure and in patients diagnosed with COPD. The issue of applicability is relevant because affordable pulse oximeters have become available for use in primary care and we need to establish what role this instrument may have in daily patient care. The list of indications we generated in this study is helpful to further define this role and may also serve as a point of departure for further research on pulse oximetry in primary care. The second and third aims of our study were to explore SpO 2 values in patients with COPD, both in stable condition and during worsening of their symptoms. A 19% rate of SpO 2 values <92% was observed in COPD patients who presented with worsening of their respiratory symptoms. We observed correlations between disease severity (in terms of baseline airflow obstruction) and SpO 2 in COPD patients with worsening symptoms, but not in those with stable disease. In the stable disease group, only 6% had an SpO 2 <92% and an association between the self-reported level of exercise-related dyspnoea (MRC score) and SpO 2 , but not between severity of obstruction and SpO 2 was observed.
Comparison with literature
The 19% rate of SpO 2 values <92% we found in the COPD patients who consulted one of the participating FPs with worsening of their symptoms is very similar to the 20% rate reported by Jones et al. 9 in a larger primary care cohort of COPD patients. Our study was not designed to establish the actual impact of pulse oximetry on FPs' decision making and conduct. However, when exploring the data obtained in our Study II, we observed that (according to the FPs' self-reports) the use of the pulse oximeter might have influenced their decision making in 45% of cases. In the study reported by Jones et al. 9 based on similar self-reports, pulse oximetry affected FPs' medical decision making in 19% of patients with COPD. Likely explanations for the substantial difference between these two studies may be the fact that the patients in our study always presented with worsening of their symptoms (which was not the case in the study by Jones et al. 9 ) and the fact that many of the patients in our study were seen during out of office hours in a family practice cooperative; in most cases these patients were previously unknown to the FP who reported the case for the study.
It is important to realize that primary care patients like the ones in our study are quite different from patients considered in hospital-based studies. A recent Turkish study in patients with severe COPD admitted to an emergency department with acute exacerbations showed that both SpO 2 and FEV 1 had a rather high sensitivity in reflecting hypoxaemia and hypercapnia (83.9 and 90.3%, respectively). 13 However, the group of patients included in our study (Study II) comprised patients with severity grades ranging from mild to severe disease. This means that the findings regarding sensitivity and specificity of pulse oximetry in the aforementioned study by Guryay et al. 13 are probably not applicable for the family practice setting. Another interesting observation in that particular study was that dyspnoea score had an even higher sensitivity (93.5%) in reflecting hypoxaemia in COPD exacerbations. Unfortunately, we did not include a standardized assessment of dyspnoea in our Study II, which would have enabled us to investigate the relationship between the severity of dyspnoea and SpO 2 -similar to our analyses of the patients with stable COPD in Study III.
Strengths and limitations of the studies
Some aspects of the methodology of the studies reported in this paper need to be addressed. The number of FPs that we were able to involve in Study I (n = 11) was rather limited, but budgetary restrictions did not allow us to increase this number. Replication of our study in other FP panels-preferably in other countries and health care settings-may reveal additional indications for pulse oximetry. Our study was not designed to provide a full assessment of the diagnostic or prognostic value of pulse oximetry in family practice. However, now that we have an overview of what the various indications for pulse oximetry in (Dutch) family practice are, a prospective cohort of unselected primary care patients could be compiled to establish this. A properly designed randomized controlled trial would be required to establish the safety and effects on decision making of routine use of pulse oximetry by FPs in the (predominant) indications for the test.
Implications for clinical practice
An interesting observation was the presence of a moderate to strong correlation between the severity of airflow obstruction (FEV 1 % predicted) and SpO 2 in the COPD patients who presented with an acute exacerbation or worsening of dyspnoea (r = 0.55 and r = 0.31, respectively), whereas no relevant correlation was observed in the patients with stable COPD (r = 0.19). These observations suggest that with regard to primary care COPD, pulse oximetry is mainly useful in patients with (very) severe airflow obstruction (FEV 1 % predicted <50%) and worsening of symptoms. This coincides with previous observations from a Spanish study in stable COPD patients, which showed that the rate of tests with SpO 2 <92% increases when the FEV 1 % predicted value is <50%. 12 The association between the level of impairment (i.e. MRC score) and SpO 2 values we observed in our study may be a reason to add pulse oximetry to the regular monitoring of all primary care patients with COPD with an MRC score >2, not just in patients who show severe obstruction. Several clinical guidelines for the management of COPD already recommend monitoring saturation, but only in patients with severe disease. [14] [15] [16] [17] Although more evidence is needed before this can be recommended for primary care, pulse oximetry may be helpful to identify those patients who might benefit from pulmonary rehabilitation or (mobile) oxygen therapy. The use of pulse oximetry as an adjunct to assessing asthma exacerbations 1 and severity of lower respiratory tract infections may support FPs' decisions to admit or treat the patient in the community.
It has been shown that clinically important overestimation of arterial oxyhaemoglobin saturation with pulse oximeters should be considered in case of SpO 2 values <80%, 18 especially in those with darkly pigmented skin. 19 Although we observed only one SpO 2 value <80% in a patient with severe COPD, this is something that FPs who use a pulse oximeter should take into account.
Finally, pulse oximetry should be considered an adjunct to the diagnostic assessment of patients, not a full diagnostic tool by itself. Although pulse oximetry appears to have added value in the clinical assessment of patients, FPs need to be cautious with its interpretation: the clinical picture still comes first, pulse oximetry should be considered only as an additional aid for decision making, not as a substitute for solid clinical assessment.
Conclusions
In conclusion, pulse oximetry appears to have a wide range of disparate indications for FPs' assessment of patients in acute as well as non-acute situations. FP's experienced in its use attach most value to pulse oximetry in patients with acute (worsening of) dyspnoea, patients suspected to suffer from respiratory insufficiency or failure and in patients with chronic obstructive conditions-especially COPD. In patients with COPD who present with worsening of their respiratory status, pulse oximetry is most likely to support FPs' clinical assessment in those patients known to have severe obstruction. In stable COPD, pulse oximetry may be useful in the monitoring of patients with disability in terms of exercise-related dyspnoea (i.e. MRC score >2).
